BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 1337403)

  • 1. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
    Lehmann R; Joller H; Haagmans BL; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
    J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
    Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
    Westman ME; Malik R; Norris JM
    Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
    Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha responses are depressed and interleukin-6 responses unaltered in feline immunodeficiency virus infected cats.
    Ma J; Kennedy-Stoskopf S; Sellon R; Tonkonogy S; Hawkins EC; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):35-50. PubMed ID: 7618260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
    Rideout BA; Moore PF; Pedersen NC
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva.
    Westman ME; Malik R; Hall E; Norris JM
    Comp Immunol Microbiol Infect Dis; 2016 Jun; 46():66-72. PubMed ID: 27260813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
    J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.
    Hofmann-Lehmann R; Holznagel E; Ossent P; Lutz H
    Clin Diagn Lab Immunol; 1997 Jan; 4(1):33-42. PubMed ID: 9008278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
    AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and factors associated with feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) in cats of the state of Santa Catarina, Brazil.
    Biezus G; Machado G; Ferian PE; da Costa UM; Pereira LHHDS; Withoeft JA; Nunes IAC; Muller TR; de Cristo TG; Casagrande RA
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():17-21. PubMed ID: 30961813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline leukaemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination.
    Bandecchi P; Dell'Omodarme M; Magi M; Palamidessi A; Prati MC
    Vet Rec; 2006 Apr; 158(16):555-7. PubMed ID: 16632529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
    Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects.
    Arjona A; Escolar E; Soto I; Barquero N; Martin D; Gomez-Lucia E
    J Clin Microbiol; 2000 Sep; 38(9):3448-9. PubMed ID: 10970400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.
    Pedersen NC; Torten M; Rideout B; Sparger E; Tonachini T; Luciw PA; Ackley C; Levy N; Yamamoto J
    J Virol; 1990 Feb; 64(2):598-606. PubMed ID: 2153226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.